Xbrane Biopharma
0.149 SEK -3.87%2 investors are following this company
Xbrane Biopharma is a biotechnology company. The company specializes in research and development of drugs for the treatment of critical illnesses. Today, the business is focused on research in microspherical technology and in the development of protein molecules. The products are used in the treatment of prostate cancer and endometriosis, as well as in rare and serious eye diseases. The company's head office is located in Solna.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
NASDAQ Stockholm
XBRANE
Daily low / high price
0.146 / 0.155
SEK
Market cap
227.89M SEK
Turnover
1.73M SEK
Volume
12M
Latest videos
Financial calendar
Interim report
2024-10-24
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Ashkan Pouya | 11.9 % | 11.9 % |
Håkan Stödberg | 4.7 % | 4.7 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Xbrane Biopharma, Webcast with teleconference, Q2'24
Xbrane Biopharma publicerar delårsrapport för januari-juni 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools